Delivery Order SPE2DB20D2014-SPE2DB24FC54E

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,529.24 firm fixed-price contract is for the supply of cefazolin 2 g/50 ml dextrose, a critical intravenous antibiotic medication. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,445.28 firm fixed price contract is for the delivery of Cefazolin 2 g/50 ml-dextrose, a critical antibiotic medication, with a performance period through November 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $4,335.84 and an ultimate completion date of August 13, 2024. It is a firm fixed-price contract, with no set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of cefazolin 2 g/50 ml-dextroses, a critical care medication, with a ceiling value of $21,285.04 and a completion date of September 12, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cefazolin 2 g/50 mL-dextrose medication. The contract has a ceiling value of $2,123.62 and is a firm fixed-price delivery order that runs through August 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.08, is for the supply of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract is a Firm Fixed Price agreement with a period of performance through January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cefazolin 2 G/50 ML-Dextroses. The contract is a Delivery Order with a Firm Fixed Price and a ceiling value of $3,915.40. The ultimate completion date is August 15, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Cefazolin 2 g/50 ml-dextroses to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,583.28, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,662,455 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract has a ceiling value of $15,175.44 and an ultimate completion date of September 4, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical supplies to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is for the supply of Cefazolin 2 g/50 mL dextrose injectable medication to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC54E
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 2 g/50 ml-dextrose, a critical care medication. The award has a ceiling value of $1,583.28 and an ultimate completion date of July 23, 2024. The contract is a firm-fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support military healthcare programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/21/24, 9:30 AM